% alzhub.org library filter
% Source: https://alzhub.org/research?author=Wilcock+GK
% 12 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{winblad2008-18322263,
  author  = {Winblad, B. and Gauthier, S. and Scinto, L. and Feldman, H. and Wilcock, G. K. and Truyen, L. and Mayorga, A. J. and Wang, D. and others},
  title   = {{Safety and efficacy of galantamine in subjects with mild cognitive impairment}},
  journal = {Neurology},
  year    = {2008},
  doi     = {10.1212/01.wnl.0000303815.69777.26},
  pmid    = {18322263},
  url     = {https://doi.org/10.1212/01.wnl.0000303815.69777.26}
}

@article{gauthier2016-27863809,
  author  = {Gauthier, S. and Feldman, H. H. and Schneider, L. S. and Wilcock, G. K. and Frisoni, G. B. and Hardlund, J. H. and Moebius, H. J. and others},
  title   = {{Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial}},
  journal = {Lancet (London, England)},
  year    = {2016},
  doi     = {10.1016/s0140-6736(16)31275-2},
  pmid    = {27863809},
  url     = {https://doi.org/10.1016/s0140-6736(16)31275-2}
}

@article{wilcock2008-18450517,
  author  = {Wilcock, G. K. and Black, S. E. and Hendrix, S. B. and Zavitz, K. H. and Swabb, E. A. and Laughlin, M. A. and {Tarenflurbil Phase II Study investigators}},
  title   = {{Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial}},
  journal = {The Lancet. Neurology},
  year    = {2008},
  doi     = {10.1016/s1474-4422(08)70090-5},
  pmid    = {18450517},
  url     = {https://doi.org/10.1016/s1474-4422(08)70090-5}
}

@article{wilcock2000-11110737,
  author  = {Wilcock, G. K. and Lilienfeld, S. and Gaens, E.},
  title   = {{Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2000},
  doi     = {10.1136/bmj.321.7274.1445},
  pmid    = {11110737},
  url     = {https://doi.org/10.1136/bmj.321.7274.1445}
}

@article{wischik2026-41570392,
  author  = {Wischik, C. M. and Stefanacci, R. and Bentham, P. and Gauthier, S. and Zetterberg, H. and Wilcock, G. K. and Froelich, L. and Burns, A. and MacSweeney, E. and Ballard, C. and others},
  title   = {{Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer's Disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100480},
  pmid    = {41570392},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100480}
}

@article{itzhaki1997-9014911,
  author  = {Itzhaki, R. F. and Lin, W. R. and Shang, D. and Wilcock, G. K. and Faragher, B. and Jamieson, G. A.},
  title   = {{Herpes simplex virus type 1 in brain and risk of Alzheimer's disease}},
  journal = {Lancet (London, England)},
  year    = {1997},
  doi     = {10.1016/s0140-6736(96)10149-5},
  pmid    = {9014911},
  url     = {https://doi.org/10.1016/s0140-6736(96)10149-5}
}

@article{love1999-10071053,
  author  = {Love, S. and Barber, R. and Wilcock, G. K.},
  title   = {{Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {1999},
  doi     = {10.1093/brain/122.2.247},
  pmid    = {10071053},
  url     = {https://doi.org/10.1093/brain/122.2.247}
}

@article{vedhara1999-10030328,
  author  = {Vedhara, K. and Cox, N. K. and Wilcock, G. K. and Perks, P. and Hunt, M. and Anderson, S. and Lightman, S. L. and Shanks, N. M.},
  title   = {{Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination}},
  journal = {Lancet (London, England)},
  year    = {1999},
  doi     = {10.1016/s0140-6736(98)06098-x},
  pmid    = {10030328},
  url     = {https://doi.org/10.1016/s0140-6736(98)06098-x}
}

@article{bucks1996-8670538,
  author  = {Bucks, R. S. and Ashworth, D. L. and Wilcock, G. K. and Siegfried, K.},
  title   = {{Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale}},
  journal = {Age and ageing},
  year    = {1996},
  doi     = {10.1093/ageing/25.2.113},
  pmid    = {8670538},
  url     = {https://doi.org/10.1093/ageing/25.2.113}
}

@article{tyler2002-12445809,
  author  = {Tyler, S. J. and Dawbarn, D. and Wilcock, G. K. and Allen, S. J.},
  title   = {{alpha- and beta-secretase: profound changes in Alzheimer's disease}},
  journal = {Biochemical and biophysical research communications},
  year    = {2002},
  doi     = {10.1016/s0006-291x(02)02635-9},
  pmid    = {12445809},
  url     = {https://doi.org/10.1016/s0006-291x(02)02635-9}
}

@article{esiri1997-9416809,
  author  = {Esiri, M. M. and Wilcock, G. K. and Morris, J. H.},
  title   = {{Neuropathological assessment of the lesions of significance in vascular dementia}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {1997},
  doi     = {10.1136/jnnp.63.6.749},
  pmid    = {9416809},
  url     = {https://doi.org/10.1136/jnnp.63.6.749}
}

@article{francis1999-10071091,
  author  = {Francis, P. T. and Palmer, A. M. and Snape, M. and Wilcock, G. K.},
  title   = {{The cholinergic hypothesis of Alzheimer's disease: a review of progress}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {1999},
  doi     = {10.1136/jnnp.66.2.137},
  pmid    = {10071091},
  url     = {https://doi.org/10.1136/jnnp.66.2.137}
}